{"id":1315398,"title":"DSEN Abstract: Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-04","captureTimestamp":"2026-02-04T10:22:14.144000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51391.html","snippet":"DSEN Abstract Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: George Wells, Doug Coyle,…","rawSnapshotUrl":"/api/snapshots/raw/1315398","browseUrl":"https://replay.healtharchive.ca/job-8/20260204102214/https://cihr-irsc.gc.ca/e/51391.html#ha_snapshot=1315398","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}